Chromagen is a biotechnology company with a core fluorescent technology platform which is being used to develop ultrasensitive biologic assays
for drug discovery, research and clinical diagnostics.
The Arizona Cancer Center will conduct biologic assays
to screen TRAP-generated compounds for pharmacologic activity against cancer-related drug targets.
Through this previously announced collaboration, the Arizona Cancer Center is conducting biologic assays
to screen TRAP-generated compounds for pharmaceutical activity against cancer-related drug targets.
First, the biologic assays
skewed the basis for comparison toward the modern drug discovery model because those assays screen mainly for illnesses faced by temperate-zone populations, and not for health problems such as malaria or tuberculosis that are far more common in the tropics where the plants grow.
Jiang has been developing and performing immunologic and molecular biologic assays
in the Rickettsial Diseases Department of the Naval Medical Research Center, Silver Spring, Maryland, for >5 years.